• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.

作者信息

Goldenberg I S

出版信息

Cancer. 1969 Jan;23(1):109-12. doi: 10.1002/1097-0142(196901)23:1<109::aid-cncr2820230112>3.0.co;2-1.

DOI:10.1002/1097-0142(196901)23:1<109::aid-cncr2820230112>3.0.co;2-1
PMID:4884063
Abstract
摘要

相似文献

1
Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.δ-1-睾丸内酯（NSC 23759）、醋酸甲羟孕酮（NSC 26386）和醋酸奥昔酮（NSC 47438）用于晚期女性乳腺癌的临床试验。合作乳腺癌研究组报告
Cancer. 1969 Jan;23(1):109-12. doi: 10.1002/1097-0142(196901)23:1<109::aid-cncr2820230112>3.0.co;2-1.
2
Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.1-睾酮内酯（NSC - 23759）与雌激素 - 孕激素联合制剂（NSC - 77622）治疗转移性乳腺癌的比较。
Cancer Chemother Rep. 1970 Aug;54(4):249-53.
3
High-dosage delta-1-testololactone therapy of disseminated carcinoma of the breast.
Cancer. 1967 Mar;20(3):458-61. doi: 10.1002/1097-0142(1967)20:3<458::aid-cncr2820200314>3.0.co;2-u.
4
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].醋酸甲地孕酮与醋酸甲羟孕酮治疗转移性乳腺癌的多中心III期研究中期报告
Onkologie. 1987 Apr;10(2):104-6. doi: 10.1159/000216383.
5
[Which hormone therapy should be used in advanced breast carcinoma in males?].男性晚期乳腺癌应使用哪种激素疗法？
Dtsch Med Wochenschr. 1988 Sep 2;113(35):1358-61. doi: 10.1055/s-2008-1067820.
6
Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.晚期乳腺癌的二线内分泌治疗——醋酸甲羟孕酮与氨鲁米特的随机交叉研究
Acta Oncol. 1996;35 Suppl 5:75. doi: 10.3109/02841869609083975.
7
A dose response evaluation of delta-1-testololactone in advanced breast cancer.
Cancer. 1974 Jan;33(1):9-13. doi: 10.1002/1097-0142(197401)33:1<9::aid-cncr2820330104>3.0.co;2-#.
8
[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].
Fortschr Med. 1987 Jul 30;105(22):421-4.
9
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
Onkologie. 1987 Oct;10(5):321-3. doi: 10.1159/000216433.
10
Combined androgen and antimetabolite therapy of advanced female breast cancer. A report of the cooperative breast cancer group.晚期女性乳腺癌的雄激素与抗代谢药物联合治疗。乳腺癌协作组报告。
Cancer. 1975 Aug;36(2):308-10. doi: 10.1002/1097-0142(197508)36:2<308::aid-cncr2820360203>3.0.co;2-1.

引用本文的文献

1
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.糖皮质激素对非血液系统恶性肿瘤临床疗效的系统评价
BMC Cancer. 2008 Mar 28;8:84. doi: 10.1186/1471-2407-8-84.
2
First generation aromatase inhibitors--aminoglutethimide and testololactone.第一代芳香化酶抑制剂——氨鲁米特和睾内酯。
Breast Cancer Res Treat. 1994;30(1):57-80. doi: 10.1007/BF00682741.
3
Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes.
Cancer Chemother Pharmacol. 1980;4(4):267-9. doi: 10.1007/BF00255272.
4
Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer.
Cancer Chemother Pharmacol. 1985;14(2):112-5. doi: 10.1007/BF00434347.
5
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.
Breast Cancer Res Treat. 1991 Aug;18(3):171-7. doi: 10.1007/BF01990033.
6
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.晚期乳腺癌中使用的内分泌药物的临床药代动力学
Clin Pharmacokinet. 1992 May;22(5):327-58. doi: 10.2165/00003088-199222050-00002.
7
High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy.
Cancer Chemother Pharmacol. 1979;2(3):175-80. doi: 10.1007/BF00258291.
8
Treatment of intra-abdominal and abdominal wall desmoid tumors with drugs that affect the metabolism of cyclic 3',5'-adenosine monophosphate.使用影响环磷酸腺苷代谢的药物治疗腹腔内及腹壁硬纤维瘤。
Ann Surg. 1975 Mar;181(3):299-302. doi: 10.1097/00000658-197503000-00009.